Related Experiment Video

Updated: May 31, 2026

Knee Arthrocentesis in Adults
04:41

Knee Arthrocentesis in Adults

Published on: February 25, 2022

[Antibiotic therapy of bone and joint infections in children: recent changes]

M Lorrot1, C Doit, B Ilharreborde

  • 1Service de pédiatrie générale, hôpital Robert-Debré, 48, boulevard Sérurier, 75019 Paris, France. mathie.lorrot@rdb.aphp.fr

Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|July 8, 2011
PubMed

Insights

Early antibiotic treatment for pediatric bone and joint infections against Staphylococcus aureus and Kingella kingae is crucial. Guidelines recommend 4-7 days IV therapy followed by 3 weeks of oral antibiotics for uncomplicated cases.

Area of Science:

  • Pediatric Infectious Diseases
  • Orthopedic Infections
  • Microbiology

Background:

  • Bone and joint infections in children require prompt management.
  • Staphylococcus aureus and Kingella kingae are common pathogens.
  • Previous guidelines for pediatric antibiotherapy were established in 2007.

Purpose of the Study:

  • To outline current management strategies for pediatric bone and joint infections.
  • To detail recommended antibiotic regimens.
  • To provide guidance on surgical intervention when necessary.

Main Methods:

  • Review of existing literature and guidelines.
  • Focus on antibiotic selection and duration.
  • Consideration of surgical drainage for abscesses or septic arthritis.

Main Results:

  • Early appropriate antibiotic therapy is key.
  • Intravenous therapy for 4-7 days followed by 3 weeks of oral therapy is recommended.
  • Surgical drainage may be necessary for complicated cases.

Conclusions:

  • Effective management relies on timely and targeted antibiotic treatment.
  • Adherence to established guidelines ensures optimal outcomes for pediatric bone and joint infections.
  • A combination of antibiotic therapy and surgical intervention, when indicated, is essential.

More Related Videos

Treatment with Vancomycin Loaded Calcium Sulphate and Autogenous Bone in an Improved Rabbit Model of Bone Infection09:09

Treatment with Vancomycin Loaded Calcium Sulphate and Autogenous Bone in an Improved Rabbit Model of Bone Infection

Published on: March 14, 2019

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...